Study of the immunoprofile of basal cell adenoma (emphasizing its relation to intercalated duct lesion) and myoepithelial cells influenced by factors in the tumor microenvironment

Author(s)

Victor Angelo Martins Montalli

• Document type: Doctoral Thesis
• Press: Campinas, SP.
• Institution: Universidade Estadual de Campinas (UNICAMP). Faculdade de Ciências Médicas
• Defense date: 2014-04-23

Examining board members

Albina Messias de Almeida Milani Altemani; Ney Soares de Araujo; Suzana Cantanhede Orsini Machado de Sousa; Maria Letícia Cintra; Fernanda Viviane Mariano

• Advisor: Elizabeth Ferreira Martinez; Albina Messias de Almeida Milani Altemani

Abstract

Salivary tumor lesions composed of dual cell population (epithelial and myoepithelial) are considered to originate from the intercalated duct. These lesions are subdivided into several entities that share morphological features. Among the benign tumors are pleomorphic adenomas (PA) and basal cell adenoma (BCA). Recently, a new entity was described that is a benign tumor with epithelial and myoepithelial composition, called intercalated duct lesion (IDL). Our first objective was to analyze the morphological and immunohistochemical profiles of IDLs and BCAs classified into tubular (T-BCA) and non-tubular subtypes (NT-BCA), to determine whether or not IDL and tubular BCA represent distinct entities. Also, given the critical role of myoepithelial cells in the morphogenesis of the salivary tumor lesions histogenetically related to the intercalated duct, our second objective was to evaluate in vitro the influence of tumor microenvironment factors (extracellular matrix proteins and growth factors) on the morphology, viability and proliferation of myoepithelial cells arisen from PA . Eight IDLs, nine tubular BCAs and 19 non-tubular BCAs were studied by immunohistochemical technique. All tubular BCAs contained IDL-like areas, which represented 20-70% of the tumor. In non-tubular BCA, IDL-like areas were occasional and small (<5%). One patient presented IDLs, tubular BCAs and IDL/tubular BCA combined lesions. Luminal ductal cells of IDLs and tubular BCAs exhibited positivity for CK7, lysozyme, S100 and DOG1. In the non-tubular BCA group, few luminal cells exhibited such immunoprofile; they were mainly CK14-positive. Basal/myoepithelial cells of IDLs, tubular BCAs and non-tubular BCAs were positive for CK14, calponin, ?-SMA and p63; they were more numerous in BCA lesions. The in vitro study analyzed morphology and differentiation of myoepithelial cells by vimentin and SMA expressions, respectively, which were qualitatively assessed using indirect immunofluorescence. Myoepithelial cells showed polyhedral morphology in all extra cellular matrixes regardless of the supplementation of growth factors. These cells expressed SMA heterogeneously but when TGF- ?1 was added such expression increased. This modification did not show relationship with the type of extracellular matix. The viability of myoepithelial cells cultured on fibronectin matrix increased significantly with addition of TGF - ?1. Conclusions: IDL, tubular BCA and non-tubular BCA form a continuum of lesions in which IDLs are related closely to tubular BCA. In both, the immunoprofile of luminal and myoepithelial cells recapitulates the normal intercalated duct. The difference between the adenoma-like subset of IDLs and tubular BCA rests mainly on the larger numbers of myoepithelial cells in the latter. Our findings indicate that at least some BCAs can arise via IDLs. The cell culture studies suggest that the different matrixes do not influence the morphology and differentiation of myoepithelial cells. Among the growth factors studied, only TGF - ?1 was associated with an increased expression of SMA (cell differentiation) and a significant increase of the cellular viability associated with the fibronectin matrix (AU)

• FAPESP's process: 11/10366-7 - IMMUNOPROFILE OF BASAL CELL ADENOMA (EMPHASIZING ITS RELATIONSHIP WITH THE INTERCALATED DUCT LESION) AND MYOEPITHELIAL CELLS (INFLUENCED BY FACTORS OF TUMOR MICROENVIRONMENT)
• Grantee: Victor Angelo Martins Montalli
• Support Opportunities: Scholarships in Brazil - Doctorate